Congenital muscular dystrophy Muscular dystrophy Laminopathie Diagnosis Heart failure Regeneration Myotonic Dystrophy Trinucleotide repeat expansion CRISPRi Biomarker Fibrosis Satellite cells Glutamate Dermatomyositis Clinical trials Astrocyte Skeletal muscle Satellite cell Cytoskeleton Myogenesis Becker muscular dystrophy Animals Actin Long read sequencing MBNL Thymus Gene therapy Laminopathy Rare diseases Male OPMD Inflammation Myasthenia gravis Myoblasts Heart Humans Cytokines AAV ALS Mouse model Outcome measures COVID-19 Motoneuron Aged Transgenic mouse model Myotonic dystrophy type 1 Genotype phenotype correlation Calcium Myasthenia Gravis MG Cancer Myotonic Dystrophy type 1 Alternative splicing Muscle Autoimmune diseases Cell therapy Aging Dystrophin Neuromuscular diseases Myopathy Duchenne muscular dystrophy Centronuclear myopathy Cardiomyopathy Treatment Brain Therapy LMNA gene Fabry disease Dilated cardiomyopathy Lamin A/C Exercise CTG repeat contractions Laminopathies Transcriptomics Myositis LMNA Biomarkers RNA interference Myopathies Muscle regeneration DMD Myotonic dystrophy Nuclear envelope Thérapie génique Lamin A/C LMNA gene Errance diagnostique Congenital myopathy Rare neuromuscular diseases Neuromuscular junction Autoantibodies Autophagy Mechanotransduction Autoimmunity Antisense oligonucleotides PABPN1 CMS Neuromuscular disease FSHD Amyotrophic lateral sclerosis RNA biology Dynamin 2